目录产品 » SARS-CoV-2 RBD Neutralization Antibody (R323IgM)
Manual
SDS
COAs

SARS-CoV-2 RBD Neutralization Antibody (R323IgM)

SARS-CoV-2 RBD Neutralization Antibody (R323IgM)
询价
V80302

Description

SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. Neutralizing antibodies against SARS-CoV-2 can block the interaction between SARS-CoV-2 RBD and ACE2. It can be used in the assessment and development of assays for the detection and quantitation of SARS-CoV-2 neutralizing antibodies.
产品概述
Specificity SARS-CoV-2 Spike Protein S1 subunit and its RBD domain
返回

产品属性
Production
Cultured in vitro under conditions free from animal-derived components
Purification Affinity chromatography
Formulation PBS, pH 7.2, containing 0.02% sodium azide.
Concentration ≥ 2 mg/ml
Clone ID R323IgM
返回

图例
SARS-CoV-2 RBD Neutralization Antibody (R323IgM)

»

<
>

技术背景
Target Background SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. Neutralizing antibodies against SARS-CoV-2 can block the interaction between SARS-CoV-2 RBD and ACE2. It can be used in the assessment and development of assays for the detection and quantitation of SARS-CoV-2 neutralizing antibodies.
返回